Indonesia Urges Greater Transparency in Cross-Border Copyright Royalty Governance Before 35 Countries 
SaunaKits.com Opens Its Upstate South Carolina Showroom, Bringing Hands-On Sauna Shopping to the Southeast 
Encore Construction Shares Guidance to Help Homeowners Avoid Costly Water Damage Insurance Claim Mistakes Introducing the Creci Impact Investing Platform, Bringing Impact Investing to the Mainstream, Supporting the Work of Companies Focused on Sustainability
With as little as $10, U.S. investors are now able to financially support growing impact…
SMART Modular Technologies Announces New DuraMemory DDR5 VLP RDIMM
The industry’s first DDR5 VLP RDIMM for high-density 1U blade compute and storage applications NEWARK,…
Antora Energy Raises More Than $50M to Decarbonize Heavy Industry With Renewable Heat and Power as Cheap as Fossil Fuels
Breakthrough Energy Ventures and Lowercarbon Capital co-led Antora’s recent round to zero out emissions in…
Egan-Jones Releases Risk Commentary – Festering Wounds and Threats From Bread, Tea, and Onions
NEW YORK–(BUSINESS WIRE)–Egan-Jones Ratings Company releases its latest Risk Commentary issue entitled, “Festering Wounds and…
Code42 Delivers Three Consecutive Years of Triple-Digit Growth Across its Insider Risk Management Business
Company doubles annual recurring revenue for Incydr solution in 2021 and advances Insider Risk Management…
U.S. Xpress Releases Economic Forecast for First Half of 2022
CHATTANOOGA, Tenn.–(BUSINESS WIRE)–U.S. Xpress Enterprises, Inc. (NYSE: USX) today released its economic forecast covering the…
New Study Uncovers the Risky Behaviors of Employees Which Could Lead to Security Breaches in Highly Regulated Industries
Key Findings: 41% of employees say security policies restrict the way they work; 36% of…
New interim CEO
CEO Kjell-Erik Nordby is currently on sick-leave, and the Board in Vistin Pharma, with effect…
Hillstream BioPharma Receives Orphan Drug Designation for HSB-1216 for the Treatment of Uveal Melanoma
–Uveal melanoma is an aggressive intraocular malignancy with a poor prognosis in which 50% of…
Lowell Farms to Announce Fourth Quarter and Fiscal Year 2022 Financial and Operational Results
Cannabis industry leader to hold conference call on March 1 SALINAS, Calif., Feb. 16, 2022…
KK Women’s and Children’s Hospital and PacBio Collaborate in Asia’s First Study of Unexplained Neurodevelopmental Disorders
PacBio HiFi Sequencing Technology Will Be Used to Investigate Effect on Diagnostic Yield of Unresolved…
Progenity Shares Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of Gastroenterology
Dr. Bram Verstockt presented key patient data establishing correlation between drug levels in colon and…
T2 Biosystems Announces Commercial Expansion Through Distributors in Norway, Finland and Türkiye
LEXINGTON, Mass., Feb. 16, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in…
Allogene Therapeutics to Report Fourth Quarter and Year-End 2021 Financial Results on February 23, 2022
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET SOUTH SAN FRANCISCO, Calif.,…
eFFECTOR Appoints Kristen Harrington-Smith to Board of Directors
SAN DIEGO and REDWOOD CITY, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics (NASDAQ:…
Skye Bioscience Reports Positive Results for SBI-100 in GLP Toxicology Study
Initiation of Phase 1 clinical trial of SBI-100 ophthalmic nanoemulsion expected in the second quarter…
Spero Therapeutics Announces Positive Topline Results from Phase 1 Bronchoalveolar Lavage Clinical Trial of SPR206, A Novel Intravenous Next Generation Polymyxin Antibiotic for the Treatment of Multi-drug Resistant Gram-Negative Infections in the Hospital Setting
SPR206 shown to be well-tolerated; achieved lung exposures consistent with predicted therapeutic levels, when administered…
Dyve Biosciences to Present at the 32nd Annual Oppenheimer Healthcare Conference
CAMARILLO, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) — Dyve Biosciences, Inc. (“Dyve”), a clinical-stage biotech…
Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2021 Financial Results
SAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate…
Outbrain Releases Engagement Bid Strategy: an AI Based Campaign Optimization Tool Built for a Cookieless World
Engagement Bid strategy (EBS) is a new AI based performance optimization solution from Outbrain that…